Report Description

India cefixime market is expected to grow at a steady rate during the forecast period. The India cefixime market is driven by high use of this medication to treat a number of bacterial infections. It works by killing bacteria or preventing their growth. Additionally, the drug is also used to treat typhoid fever which is further expected to boost the demand through FY2026. Improvement in healthcare infrastructure is further predicted to bolster the market growth in the years to come.

The India cefixime market is segmented based on route of administration, dose, source, form, distribution channel, application, end user, company, and region. Based on form, the market is segmented into tablet, capsule, suspension, others. Among them, the tablet segment dominated the market until 2019 and is further projected to maintain its dominance in the market during then forecast years as well on account of their longer shelf life than the alternatives. Also, the capsule segment is anticipated to grow at a high CAGR in the market over the next 5 years because capsules are considered as fast-acting and often more powerful than tablet owing to fact that it only takes few minutes for a liquid filled capsule to disintegrate and get absorbed into the bloodstream, while it can take 20-30 minutes for a tablet pill to be absorbed in the human body.

The major players operating in the India cefixime market are Covalent Laboratories Pvt. Ltd, Reva Pharma Pvt. Ltd., Orchid Pharma Ltd., Unimark Remedies Ltd., Virchow Healthcare Pvt. Ltd., Alkem Laboratories Limited, Aurobindo Pharma Limited, Taj Pharmaceuticals Ltd., Lupin Pharmaceuticals Pvt. Ltd., Dr. Reddy’s Laboratories Ltd. and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies, and launching new products in order to stay competitive in the market. Other Go-to-Market growth strategies include mergers & acquisitions, joint ventures, and new product developments in order to sustain themselves amidst fierce competition.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India cefixime market from FY2016 to FY2019.
  • To estimate and forecast the market size of India cefixime market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India cefixime market based on route of administration, dose, source, form, distribution channel, application, end user, company, and regional distribution.
  • To identify dominant region or segment in the India cefixime market.
  • To identify drivers and challenges for India cefixime market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India cefixime market.
  • To identify and analyze the profile of leading players operating in India cefixime market.
  • To identify key sustainable strategies adopted by market players in India cefixime market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India cefixime market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Cefixime manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to cefixime

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India cefixime market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Cefixime Market, By Route of Administration:
    • Oral
    • Intravenous
  • India Cefixime Market, By Dose:
    • 100 mg
    • 200 mg
    • 500 mg
    • Others
  • India Cefixime Market, By Source:
    • In-house
    • Contract Manufacturing Organizations
  • India Cefixime Market, By Form:
    • Tablet
    • Capsule
    • Powder
    • Injection
    • Others
  • India Cefixime Market, By Distribution Channel:
    • Online
    • Offline
  • India Cefixime Market, By Application:
    • Urinary tract infections
    • Otitis media
    • Pharyngitis and tonsillitis
    • Others
  • India Cefixime Market, By End User:
    • Adult
    • Children
  • India Cefixime Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India cefixime market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India cefixime market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on India Cefixime Market

4.    Executive Summary

5.    Manufacturing Cefixime

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Cefixime

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Cefixime Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Route of Administration (Oral v/s Intravenous)

7.2.2.     By Dose (100 mg, 200 mg, 500 mg, Others)

7.2.3.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.4.     By Form (Tablet, Capsule, Powder, Injection, Others)

7.2.5.     By Distribution Channel (Online v/s Offline)

7.2.6.     By Application (Urinary tract infections, Otitis media, Pharyngitis and tonsillitis, Others)

7.2.7.     By End User (Adult v/s Children)

7.2.8.     By Region (North, East, South, West)

7.2.9.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Covalent Laboratories Pvt. Ltd.      Company Brief      Production Plants & Capacity (If Available)      Financials (If Available)      Captive Consumption Vs Merchant Sale      Current & Future Plans

14.1.2.  Reva Pharma Pvt. Ltd.

14.1.3.  Orchid Pharma Ltd.

14.1.4.  Unimark Remedies Ltd.

14.1.5.  Virchow Healthcare Pvt. Ltd.

14.1.6.  Alkem Laboratories Limited

14.1.7.  Aurobindo Pharma Limited

14.1.8.  Taj Pharmaceuticals Ltd.

14.1.9.  Lupin Pharmaceuticals Pvt. Ltd.

14.1.10.                Dr. Reddy’s Laboratories Ltd.

15.  Strategic Recommendations

16. About Us & Disclaimer 

Figures and Tables

Frequently asked questions






Sakshi Bajaal

Business Consultant
Press Release

India Cefixime Market to grow at a steady rate During the Forecast Period

Nov, 2020

Increase in bacterial infections is expected to drive the growth of India Cefixime market during the forecast period.